Despite certain drugs, including angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, which can effectively reduce albuminuria and slow the progression of DN (2–4), the incidence of DN has continued to increase at a high rate. The gene discussed is ACE; the disease is liver dysplastic nodule.